Yonsei University Hospital System kicks off DTx ecosystem

Yonsei University Health System has launched Connect-DTx, a platform that integrates hospitals, insurers, and medical device manufacturers to seamlessly connect the entire care process. The platform allows for the collection of real-time health data from patients using digital therapeutics (DTx) and hospital EMRs, which can be used to personalize treatments. It also facilitates communication with…

Read More

Researching a new treatment option for severe blood disorders of the bone marrow

A clinical trial led by Professor Uwe Platzbecker from the University of Leipzig Medical Center tested a new treatment combination for higher-risk myelodysplastic neoplasms (MDS). Symptoms of MDS include rapid progression, severe symptoms, and a transition to acute leukemia. Only intensive treatments like stem cell transplantation and chemotherapy are available to patients with higher-risk MDS….

Read More

Industrial vegetable oils show dangerous levels of toxic elements, surpassing traditional oils

Researchers analyzed samples of edible vegetable oils to determine if they contained potentially toxic elements. The study aimed to evaluate the health risks associated with consuming these oils in Hamadan, Iran. They found that iron, arsenic, zinc, cadmium, and lead were present in varying concentrations in these oils. While concentrations of these elements did not…

Read More

Diabetes-Friendly Meal Delivery Plans

For individuals with diabetes, choosing meals can be challenging due to nutritional concerns. A diabetes meal delivery plan can offer convenience and cost savings compared to eating out. It can also provide more control over the nutritional content of meals while helping to curb overeating. When comparing meal plans, look for those based on the…

Read More

Severe Hypocalcemia Risk in Dialysis Patients With Denosumab

A study published in JAMA found that using the osteoporosis drug denosumab (Prolia) in dialysis patients significantly increases the risk of life-threatening hypocalcemia compared to other treatments. The FDA is revising the prescribing information for the drug to include a boxed warning. Patients on dialysis have a high risk for fracture and difficulty absorbing calcium,…

Read More
error: Content is protected !!